MenB vaccine

COMBINATION_PRODUCT3 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, MeningococcalMeningitis, Meningococcal

Phase 1

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

CompletedNCT04886154

GlaxoSmithKlineInfections, Meningococcal

Start: 2021-06-14End: 2024-02-02Updated: 2025-05-31

Phase 2

A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants

CompletedNCT05082285

GlaxoSmithKlineInfections, Meningococcal

Start: 2021-11-29End: 2025-03-31Updated: 2026-06-26

Phase 3

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

CompletedNCT04707391

GlaxoSmithKlineMeningitis, Meningococcal

Start: 2021-01-25End: 2023-09-29Updated: 2024-07-03

Related Papers

Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study

Clinical Infectious Diseases2024-12-263 citations